Faecal calprotectin levels before and after weight loss in obese and overweight subjects

被引:0
作者
P Kant
R Fazakerley
M A Hull
机构
[1] Section of Molecular Gastroenterology,
[2] Leeds Institute of Molecular Medicine,undefined
[3] St James's University Hospital,undefined
来源
International Journal of Obesity | 2013年 / 37卷
关键词
calprotectin; excess body weight; inflammation; weight loss;
D O I
暂无
中图分类号
学科分类号
摘要
Faecal calprotectin (FCP) is a non-invasive biomarker of intestinal inflammation, levels of which are reported to be elevated in individuals with increased body mass index (BMI). We investigated whether weight loss (WL), induced by dietary and behavioural change in a community weight loss programme (Slimming World), was associated with a reduction in FCP in a longitudinal cohort study. We obtained paired stool samples at the start and 11–15 weeks into the weight loss programme in 40 individuals with a BMI >25 kg m−2 and no known colorectal or systemic inflammatory condition. Eight of 40 (20%) ‘healthy’ participants had a baseline FCP greater than 50 μg g−1 (the accepted adult cutoff value for FCP), termed FCPhigh. Although the degree (%) of WL was similar (5.1 FCPhigh versus 6.1 FCPnormal; P=0.63), only FCPhigh individuals, but not FCPnormal participants, demonstrated a reduction in FCP level (median 0.3-fold versus 1.0-fold (that is, no change) during the study period (P=0.065). A large prospective cohort study of FCPhigh and FCPnormal obese individuals is now required to determine the relationship between local mucosal inflammation and the systemic inflammatory state associated with obesity, as well as understand the relationship between FCP levels, WL and future risk of colorectal neoplasia.
引用
收藏
页码:317 / 319
页数:2
相关论文
共 68 条
[1]  
Gregor MF(2011)Inflammatory mechanisms in obesity Annu Rev Immunol 29 415-445
[2]  
Hotamisligil GS(2008)Increased colorectal epithelial cell proliferation and crypt fission associated with obesity and Roux-en-Y gastric bypass Cancer Epidemiol Biomarkers Prev 17 1401-1410
[3]  
Sainsbury A(2010)Diet and inflammation Nutr Clin Pract 25 634-640
[4]  
Goodlad RA(2011)Excess body weight and obesity - the link with gastrointestinal and hepatobiliary cancer Nature Rev Gastroenterol Hepatol 8 224-238
[5]  
Perry SL(2011)Intestinal inflammation and cancer Gastroenterology 140 1807-1816
[6]  
Pollard SG(2011)Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis Am J Clin Nutr 93 234-242
[7]  
Robins GG(1992)Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study Scand J Gastroenterol 27 793-798
[8]  
Hull MA(2010)Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: Diagnostic meta-analysis Br Med J 341 c3369-284
[9]  
Galland L(2004)Bowel inflammation as measured by fecal calprotectin: A link between lifestyle factors and colorectal cancer risk Cancer Epidemiol Biomarkers Prev 13 279-358
[10]  
Kant P(2009)Influence of Slimming World's lifestyle programme on diet, activity behaviour and health of particpants and their families J Hum Nutr Diet 24 351-160